Bagi maksud itu, Mahkamah merujuk kepada surat balasan kepada aduan pihak Plaintif oleh Defendan yang menyatakan bahawa terdapat kemungkinan “Complication from Transfusion & Nursing Communication” yang membawa kepada kecederaan Plaintif. Gleneagles melalui surat bertarikh 2 Ogos 2022 mengandungi pernyataan seperti yang berikut: “1. Complication from Transfusion & Nursing Communication While we have taken considerable steps to ensure the safety of our patients, we acknowledge the complaints you had highlighted during your admission from 8th June 2022 until 21st June 2022. We sincerely regret the experiences you had encountered. Mindful of what you had experienced, the complication of Acyclovir therapy is a known side effect and can develop within 24 to 48 hours of administration, with about 12 to 48% of such cases are known and documented. We are glad that your condition was reversed and normalised upon your discharge from our hospital. Moving forward, improvement processes are in place to ensure no recurrence on the transfusion matter, and the nursing team is reminded to communicate more effectively between their prescriber and the team.” (Ekshibit NZL-1 Affidavit Sokongan Plaintif) (Enc. 2).